Skip to content
drillr.ai
Sign up

688298.SH

东方生物

SSE · Healthcare · Medical - Specialties · CN

CNY 18.71
−3.71%
Ask drillr

  • Sep 3, 2026, 11:47 UTC

    OriGene Biotech and its wholly-owned subsidiary Shanghai Wanzijian Bio recently obtained multiple medical device registration certificates in China and overseas, covering syphilis antibody detection, HPV nucleic acid typing, and thyroid-stimulating hormone detection products.

    Source:

  • Aug 28, 2026, 08:28 UTC

    OriGene Biotech reported a net loss of 222 million yuan for the first half of 2026, compared with a loss of 163 million yuan in the same period of 2025.

    Source: